Advent France Biotechnology
General contacts
Investor type
VC
Founded
2015
AUM
$65 M
Location
France
$1-5 m
Investment Ticket
3-5 years
Investment Horizon
Seed,
Series A
Investment Stage
Sale to strategic investor,
IPO
Exit Strategy
Investor profile last updated: 06 December, 2025
Profile
Advent France Biotechnology focuses on ground-breaking innovations in Life Sciences to address unmet medical and clinical needs, building the next generation of pioneering healthcare companies. Keeping in mind patients’ well-being, we believe in improving medical care and taking medical innovations further ahead. We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and drive inventive Life Sciences start-ups to success.
Industry
Region of investment
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!
FAQs about Advent France Biotechnology
Where is Advent France Biotechnology located?
Advent France Biotechnology is located in France.
When was Advent France Biotechnology founded?
Advent France Biotechnology was founded in 2015.
What sectors and industries does Advent France Biotechnology invest in?
Advent France Biotechnology invests in companies and startups in Agriculture, Biotechnology, Food and Beverage, Foodtech, Healthcare Services, Medical Devices, MedTech, Life Sciences, HealthTech, AgriTech.
What is Advent France Biotechnology geographical focus of investments?
Advent France Biotechnology invests in companies and startups in Europe.
At what stages of companies and startups does Advent France Biotechnology typically invest in?
Advent France Biotechnology invests in companies and startups at Seed, Series A.
What is the usual amount of Advent France Biotechnology investment?
Advent France Biotechnology usually invests $1-5 m on average.
What is the amount of assets of under management (AUM) for Advent France Biotechnology?
Advent France Biotechnology has around $65m assets under management.